Shin, Ho Cheol <br/><br/>
Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy.  [electronic resource] 

 -  The Korean journal of internal medicine  Nov 2014 
 - 785-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2005-6648 
<br/><br/><label>Standard No.: </label>10.3904/kjim.2014.29.6.785  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Biomarkers, Tumor--analysis<br/>Chi-Square Distribution<br/>Cyclophosphamide--administration & dosage<br/>Disease Progression<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Lymphoma, Large B-Cell, Diffuse--chemistry<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>NF-kappa B--analysis<br/>Neoplasm Staging<br/>Predictive Value of Tests<br/>Prednisone--administration & dosage<br/>Proportional Hazards Models<br/>Receptors, CXCR4--analysis<br/>Retrospective Studies<br/>Risk Factors<br/>Rituximab<br/>Time Factors<br/>Treatment Outcome<br/>Vincristine--administration & dosage<br/>Young Adult